Legend Biotech

About:

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

Website: https://www.legendbiotech.com

Top Investors: RA Capital Management, Lilly Asia Ventures, Vivo Capital, Hudson Bay Capital Management, Johnson & Johnson Robotics and Digital Solutions

Description:

Legend Biotech is a clinical-stage biopharmaceutical company that discovers and develops novel cell therapies for oncology. The company develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Its initial product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma.

Total Funding Amount:

$750M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Piscataway, New Jersey, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)legendbiotech.com

Founders:

Frank Zhang